Disease activity and quality-of-life improvements in patients with Behcet's syndrome: a phase III randomized, placebo-controlled, double-blind study of apremilast (RELIEF)
Date
2018Author
Paris, M.
Hatemi, G.
Mccue, S.
Li, H.
Yazici, Y.
Melikoglu, M.
Mahr, A.
Ishigatsubo, Y.
Song, Y. W.
Cheng, S.
Metadata
Show full item recordCollections
- Makale [92796]